1. Home
  2. JAGX vs MOVE Comparison

JAGX vs MOVE Comparison

Compare JAGX & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • MOVE
  • Stock Information
  • Founded
  • JAGX 2013
  • MOVE 2018
  • Country
  • JAGX United States
  • MOVE United States
  • Employees
  • JAGX N/A
  • MOVE N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • JAGX Health Care
  • MOVE Health Care
  • Exchange
  • JAGX Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • JAGX 7.4M
  • MOVE 7.3M
  • IPO Year
  • JAGX N/A
  • MOVE 2021
  • Fundamental
  • Price
  • JAGX $5.88
  • MOVE $1.02
  • Analyst Decision
  • JAGX
  • MOVE Buy
  • Analyst Count
  • JAGX 0
  • MOVE 1
  • Target Price
  • JAGX N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • JAGX 247.5K
  • MOVE 45.0K
  • Earning Date
  • JAGX 05-15-2025
  • MOVE 05-23-2025
  • Dividend Yield
  • JAGX N/A
  • MOVE N/A
  • EPS Growth
  • JAGX N/A
  • MOVE N/A
  • EPS
  • JAGX N/A
  • MOVE N/A
  • Revenue
  • JAGX $11,689,000.00
  • MOVE $1,013,000.00
  • Revenue This Year
  • JAGX $22.41
  • MOVE $1,460.71
  • Revenue Next Year
  • JAGX $30.00
  • MOVE N/A
  • P/E Ratio
  • JAGX N/A
  • MOVE N/A
  • Revenue Growth
  • JAGX 19.75
  • MOVE N/A
  • 52 Week Low
  • JAGX $4.02
  • MOVE $0.71
  • 52 Week High
  • JAGX $502.50
  • MOVE $8.85
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 37.09
  • MOVE 45.32
  • Support Level
  • JAGX $5.30
  • MOVE $0.75
  • Resistance Level
  • JAGX $13.20
  • MOVE $1.34
  • Average True Range (ATR)
  • JAGX 1.49
  • MOVE 0.14
  • MACD
  • JAGX -0.57
  • MOVE 0.09
  • Stochastic Oscillator
  • JAGX 7.30
  • MOVE 45.58

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: